Structure-activity relationships in coumermycins.
D000818:Animals; D000900:Anti-Bacterial Agents / Q000096:biosynthesis / Q000138:chemical synthesis / Q000494:pharmacology* / Q000627:therapeutic use / Q000633:toxicity; D001419:Bacteria / Q000187:drug effects; D001424:Bacterial Infections / Q000188:drug therapy; D055598:Chemical Phenomena; D002621:Chemistry; D003374:Coumarins / Q000096:biosynthesis / Q000138:chemical synthesis / Q000494:pharmacology* / Q000627:therapeutic use / Q000633:toxicity; D004195:Disease Models, Animal; D004285:Dogs; D004352:Drug Resistance, Microbial; D006801:Humans; D051379:Mice; D009675:Novobiocin / Q000494:pharmacology; D051381:Rats; D013045:Species Specificity; D013302:Streptomyces / Q000378:metabolism; D013329:Structure-Activity Relationship
D000900:Anti-Bacterial Agents; D003374:Coumarins; D009675:Novobiocin